¹û¶³Ö±²¥ÊÓƵ

​​In August 2024, the WHO announced the ongoing mpox outbreak to be a public health emergency of international concern following a surge in cases across Africa and the emergence of a new sexually transmitted strain of the virus. This announcement has been followed by an escalation in measures to prepare for and respond to the ongoing outbreak.

​Mpox vaccines offer protection against infection and severe disease. The WHO currently recommends two vaccines against mpox (MVA-BN and LC16) or a third (ACAM2000) when the others are not available. 

​But with a shortage of doses alongside renewed concerns of ‘vaccine hoarding’, it is unclear what role vaccines will play in the global response to the current outbreak.

​In this special Vaccine Centre seminar, we will provide an update of the current mpox outbreak and the potential use of vaccines to combat the spread of the virus.

​Topics will include:

• ​An update on the current outbreak;
• ​Ongoing mpox research in Nigeria;
• Vaccine implementation and effectiveness in the UK;
• ​What vaccines are currently available and in what quantities;
• ​The optimal use of available doses given supply constraints.

​We invite attendees to join us after the seminar for drinks and networking in the Pumphandle Social.

Speakers

• Professor David Heymann

• ​Dr Chioma Achi

  Chioma joined the Department of Infectious Disease Epidemiology at LSHTM as an Assistant Professor in August 2024. She coordinates the Mpox research project, a research collaboration between the LSHTM, UK-Public Health Rapid Support Team (UK-PHRST), the University of Oxford and ODA-partners. Chioma has experience working in One Health and epidemiology, an area where she also completed her PhD. She holds a PhD from the University of Cambridge, an MSc in Applied Microbiology and Biotechnology from the University of Westminster, London where she worked on Bundibugyo Ebolavirus and a Doctor of Veterinary Medicine (DVM) degree from Ahmadu Bello University, Zaria Nigeria. Her other research interests are around Antimicrobial Resistance, Bacterial Genomics, Zoonoses and Food Safety. 

• Dr Hannah Charles

  Hannah Charles has a background in public health and microbiology, and is currently a Principal Epidemiologist at the UK Health Security Agency. Her work focused on the real-time and enhanced surveillance of sexually transmitted infections, and has involved responding to the mpox outbreak in England.

Event notices

• Please note that you can join this event in person or you can join the session remotely.
• Please note that the recording link will be listed on this page when available.